Cart
sales@molnova.com
BMY 25368 HCl
CAS No. 86134-36-3
BMY 25368 HCl( —— )
Catalog No. M33969 CAS No. 86134-36-3
BMY 25368 HCl is a competitive histamine H2 receptor antagonist that antagonizes gastric secretion stimulated by pentagastrin, ethacrynic choline, and food.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 202 | In Stock |
|
| 10MG | 299 | In Stock |
|
| 25MG | 505 | In Stock |
|
| 50MG | 715 | In Stock |
|
| 100MG | 1004 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2009 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMY 25368 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMY 25368 HCl is a competitive histamine H2 receptor antagonist that antagonizes gastric secretion stimulated by pentagastrin, ethacrynic choline, and food.
-
DescriptionBMY 25368 HCl is a competitive histamine H2 receptor antagonist that antagonizes gastric secretion stimulated by pentagastrin, ethacrynic choline, and food.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86134-36-3
-
Formula Weight379.88
-
Molecular FormulaC19H26ClN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C1C(=O)C(NCCCOC2=CC=CC(=C2)CN3CCCCC3)=C1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
S 38093 HCl
S 38093 is a novel brain-penetrant antagonist/inverse agonist of H3 receptors.
-
Cetirizine Impurity ...
Cetirizine Impurity B dihydrochloride is an impurity of Cetirizine dihydrochloride.
-
Orphenadrine hydroch...
Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions, as well as the treatment of some aspects of Parkinson's disease.
